Nabelita - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 33,808 | 344,242 | 372,396 | 455,687 | 260,258 | 81,982 | 81,534 | 126,961 |
| Profit before tax | -151,123 | 121,259 | 64,168 | 171,142 | -49,354 | -73,854 | -5,969 | 35,213 |
| Net profit | -151,123 | 121,259 | 64,168 | 166,023 | -49,354 | -73,854 | -5,969 | 33,523 |
| Equity | -149,960 | -28,700 | 35,768 | 201,792 | 152,438 | 78,583 | 72,614 | 106,138 |
| Liabilities | 394,060 | 571,631 | 487,850 | 1,087,537 | 22,086 | 25,905 | 54,739 | 12,233 |
| Non-current assets | 110,695 | 32,456 | 62,624 | 64,714 | 42,180 | 27,630 | 13,080 | 856 |
| Current assets | 131,676 | 510,475 | 460,811 | 1,224,615 | 132,344 | 76,826 | 113,918 | 117,491 |
| Total assets | 242,371 | 542,931 | 523,435 | 1,289,329 | 174,524 | 104,456 | 126,998 | 118,347 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 16,193 | 20,629 | 24,549 |
| Social insurance contributions | - | - | - | - | - | 11,065 | 6,710 | 13,918 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -10.9% | +918.2% | +8.2% | +22.4% | -42.9% | -68.5% | -0.5% | +55.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -62.4% | 22.3% | 12.3% | 12.9% | -28.3% | -70.7% | -4.7% | 28.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | 179.4% | 82.3% | -32.4% | -94.0% | -8.2% | 31.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -447.0% | 35.2% | 17.2% | 36.4% | -19.0% | -90.1% | -7.3% | 26.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -447.0% | 35.2% | 17.2% | 37.6% | -19.0% | -90.1% | -7.3% | 27.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | 13.6 | 5.4 | 0.1 | 0.3 | 0.8 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 3,028 | 20,552 | 26,600 | 49,263 | 65,065 | 21,387 | 23,295 | 31,740 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Nabelita - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-07-16 | 2025-07-20 | 273.82 |
Nabelita - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Nabelita, UAB (code 304186288) is a Private Limited Liability Company engaged in research and development in medical sciences. In 2025, revenue rose to €127.0K from €81.5K in 2024 and €82.0K in 2023, confirming a strong upward trend over the last two years. Profitability also improved materially: net profit moved from a loss of €73.9K in 2023 to a loss of €6.0K in 2024, before turning into a profit of €33.5K in 2025. This lifted the profit margin to 26.4% in the latest year. The balance sheet strengthened as well, with total assets of €118.3K, equity of €106.1K and liabilities of €12.2K at the end of 2025. The equity ratio stood at 89.7% and debt-to-equity at 0.12, indicating a conservative capital structure. Asset turnover was 1.07x, ROE 31.6% and ROA 28.3%. Revenue per employee reached €31.7K, while profit per employee was €8.4K in 2025.